Authors: Belshe, RB Gruber, WC Mendelman, PM Cho, I Reisinger, K Block, SL Wittes, J Iacuzio, D Piedra, P Treanor, J King, J Kotloff, K Bernstein, DI Hayden, FG Zangwill, K Yan, LH Wolff, M

Citation: Rb. Belshe et al., Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine, J PEDIAT, 136(2), 2000, pp. 168-175

Authors: Belshe, RB Gruber, WC Mendelman, PM Mehta, HB Mahmood, K Reisinger, K Treanor, J Zangwill, Z Hayden, FG Bernstein, DI Kotloff, K King, J Piedra, PA Block, SL Yan, LH Wolff, M

Citation: Rb. Belshe et al., Correlates of immune protection induced by live, attenuated, cold-adapted,trivalent, intranasal influenza virus vaccine, J INFEC DIS, 181(3), 2000, pp. 1133-1137

Authors: Treanor, JJ Kotloff, K Betts, RF Belshe, R Newman, F Iacuzio, D Wittes, J Bryant, M

Citation: Jj. Treanor et al., Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV)influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses, VACCINE, 18(9-10), 1999, pp. 899-906

Authors: Tacket, CO Cohen, MB Wasserman, SS Losonsky, G Livio, S Kotloff, K Edelman, R Kaper, JB Cryz, SJ Giannella, RA Schiff, G Levine, MM

Citation: Co. Tacket et al., Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba threemonths after vaccination, INFEC IMMUN, 67(12), 1999, pp. 6341-6345